We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals

136 hedge funds and large institutions have $943M invested in Syndax Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,305% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $21K

71% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 31

17% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 23

3% more funds holding

Funds holding: 132136 (+4)

0.59% less ownership

Funds ownership: 99.77%99.19% (-0.59%)

18% less capital invested

Capital invested by funds: $1.15B → $943M (-$203M)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
27
Increased
53
Reduced
31
Closed
23
Calls
$1.55M
Puts
$21K
Net Calls
+$1.53M
Net Calls Change
-$3.41M
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
151
Jane Street
New York
-$477K -21,778 Closed
SSA
152
Schonfeld Strategic Advisors
New York
-$269K -12,300 Closed
BAM
153
Blueshift Asset Management
New Jersey
-$216K -9,860 Closed
Optiver Holding
154
Optiver Holding
Netherlands
-$98K -5,147 Closed
CCA
155
Cross Creek Advisors
Utah
-$51K -2,649 Closed
ACM
156
Aquatic Capital Management
Illinois
-$11K -500 Closed
CAC
157
Cowen and Company
New York
-$8K -377 Closed